Total Equity - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Total Equity Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Total Equity
-€30.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Equity
€166.3m
CAGR 3-Years
29%
CAGR 5-Years
5%
CAGR 10-Years
2%
Nanobiotix SA
PAR:NANO
Total Equity
-€1.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Total Equity
€28.8m
CAGR 3-Years
-40%
CAGR 5-Years
-31%
CAGR 10-Years
-10%
Genfit SA
NASDAQ:GNFT
Total Equity
€68m
CAGR 3-Years
N/A
CAGR 5-Years
27%
CAGR 10-Years
17%
Eurobio Scientific SA
PAR:ALERS
Total Equity
€175m
CAGR 3-Years
18%
CAGR 5-Years
44%
CAGR 10-Years
24%

See Also

What is Gensight Biologics SA's Total Equity?
Total Equity
-30.7m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Total Equity amounts to -30.7m EUR.

What is Gensight Biologics SA's Total Equity growth rate?
Total Equity CAGR 1Y
-101%

Over the last year, the Total Equity growth was -101%.

Back to Top